Long-acting GHRH analog studied primarily for its role in visceral fat regulation and body composition research. FDA-approved (as Egrifta) for HIV-associated lipodystrophy.
Mechanism, common research protocols, evidence review, and cited primary literature for Tesamorelin live on the full guide.